Multivalent HIV-1 peptide immunogen vaccine

N/A

Report date: 2024/06/27 20:00:09

Base Information

Drug NameMultivalent HIV-1 peptide immunogen vaccine

Drug Alias NameN/A

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Synthetic peptide vaccine

Mechanisms of ActionImmunostimulantsRecombinant envelope protein inhibitors

TargetsRecombinant envelope protein

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)United Biomedical Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A